Fatta B. Nahab, MD - Publications

Affiliations: 
2008-2013 Neurology University of Miami, Coral Gables, FL 
 2013- Neurosciences University of California, San Diego, La Jolla, CA 
Area:
Neuroimaging, Movement Disorders, Tremors

30/55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Triggiani AI, Scheman K, Pirio Richardson S, Matsuhashi M, Peckham E, Nahab F, Mari Z, Ravindran S, Hallett M. Physiological and introspective antecedents of tics and movements in adults with tic disorders. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 37142497 DOI: 10.1016/j.clinph.2023.03.362  0.332
2020 Pirio Richardson S, Triggiani AI, Matsuhashi M, Voon V, Peckham E, Nahab F, Mari Z, Hallett M. Timing of the Sense of Volition in Patients With Schizophrenia. Frontiers in Neuroscience. 14: 574472. PMID 33192259 DOI: 10.3389/fnins.2020.574472  0.352
2019 Longardner K, Undurraga FV, Nahab FB, Hallett M, Haubenberger D. How Do I Assess Tremor Using Novel Technology? Movement Disorders Clinical Practice. 6: 733-734. PMID 31745492 DOI: 10.1002/Mdc3.12818  0.422
2018 Moreno GM, Gandhi R, Lessig SL, Wright B, Litvan I, Nahab FB. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine. Neurology. PMID 30258020 DOI: 10.1212/Wnl.0000000000006396  0.317
2018 Pahwa R, Isaacson SH, Torres-Russotto D, Nahab FB, Lynch PM, Kotschet KE. Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson's disease: recommendations from an expert panel. Expert Review of Neurotherapeutics. 1-12. PMID 30032695 DOI: 10.1080/14737175.2018.1503948  0.344
2017 Nahab FB, Kundu P, Maurer C, Shen Q, Hallett M. Impaired sense of agency in functional movement disorders: An fMRI study. Plos One. 12: e0172502. PMID 28448504 DOI: 10.1371/Journal.Pone.0172502  0.434
2016 Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, ... ... Nahab FB, et al. Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27753188 DOI: 10.1002/Mds.26817  0.39
2016 Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, et al. Technology in Parkinson's disease: Challenges and opportunities. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27125836 DOI: 10.1002/Mds.26642  0.327
2015 Kang SY, Im CH, Shim M, Nahab FB, Park J, Kim DW, Kakareka J, Miletta N, Hallett M. Correction: Brain Networks Responsible for Sense of Agency: An EEG Study. Plos One. 10: e0137769. PMID 26332447 DOI: 10.1371/Journal.Pone.0137769  0.37
2015 Kang SY, Im CH, Shim M, Nahab FB, Park J, Kim DW, Kakareka J, Miletta N, Hallett M. Brain Networks Responsible for Sense of Agency: An EEG Study. Plos One. 10: e0135261. PMID 26270552 DOI: 10.1371/Journal.Pone.0135261  0.394
2014 Pandey S, Nahab F, Aldred J, Nutt J, Hallett M. Post-traumatic shoulder movement disorders: A challenging differential diagnosis between organic and functional. Movement Disorders Clinical Practice (Hoboken, N.J.). 1: 102-105. PMID 25197686 DOI: 10.1002/Mdc3.12016  0.437
2014 Haubenberger D, Nahab FB, Voller B, Hallett M. Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time? Tremor and Other Hyperkinetic Movements (New York, N.Y.). 4. PMID 24587968 DOI: 10.7916/D8RX991R  0.383
2014 Kang S, Sohn Y, Im C, Nahab F, Shim M, Park J, Kim D, Kakarek J, Miletta N, Hallett M. P928: Sense of agency in motor control: an EEG study Clinical Neurophysiology. 125: S293-S294. DOI: 10.1016/S1388-2457(14)50964-9  0.383
2013 Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, Auh S, Buchwald P, Grimes GJ, Starling J, Potti G, Scheider L, Kalowitz D, Bowen D, Carnie A, et al. Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology. 80: 933-40. PMID 23408867 DOI: 10.1212/Wnl.0B013E3182840C4F  0.629
2012 Nahab FB, Handforth A, Brown T, Shin C, Quesada A, Dong C, Haubenberger D, Hallett M. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 635-8. PMID 22454323 DOI: 10.1007/S13311-012-0121-1  0.405
2011 Haubenberger D, Kalowitz D, Nahab FB, Toro C, Ippolito D, Luckenbaugh DA, Wittevrongel L, Hallett M. Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2073-80. PMID 21714004 DOI: 10.1002/Mds.23808  0.441
2011 Nahab FB, Wittevrongel L, Ippolito D, Toro C, Grimes GJ, Starling J, Potti G, Haubenberger D, Bowen D, Buchwald P, Dong C, Kalowitz D, Hallett M. An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 8: 753-62. PMID 21594724 DOI: 10.1007/S13311-011-0045-1  0.47
2011 Nahab FB, Kundu P, Gallea C, Kakareka J, Pursley R, Pohida T, Miletta N, Friedman J, Hallett M. The neural processes underlying self-agency. Cerebral Cortex (New York, N.Y. : 1991). 21: 48-55. PMID 20378581 DOI: 10.1093/Cercor/Bhq059  0.403
2011 Kang S, Sohn Y, Park J, Nahab F, Kakareka J, Miletta N, Im C, Hallett M. P3.9 Brain networks responsible for sense of agency: an EEG study Clinical Neurophysiology. 122: S68. DOI: 10.1016/S1388-2457(11)60228-9  0.39
2010 Nahab FB, Hallett M. Current role of functional MRI in the diagnosis of movement disorders. Neuroimaging Clinics of North America. 20: 103-10. PMID 19959022 DOI: 10.1016/J.Nic.2009.08.001  0.413
2010 Haubenberger D, Kalowitz D, Nahab FB, Toro C, Ippolito D, Wittevrongel L, Hallett M. Abstract #12: Computerized Essential Tremor Spirography: Development of a Rater-Independent Outcome Measure for Clinical Trials Neurotherapeutics. 7: 332-332. DOI: 10.1016/J.Nurt.2010.06.014  0.438
2010 Apter JT, Fox RJ, Cronin T, Lin J, Sakaie K, Ontaneda D, Mahmoud SY, Lowe MJ, Phillips MD, Wang X, Goldberg-Zimring D, Chavarro-Nieto CD, Healy BC, Achiron A, Warfield SK, ... ... Nahab FB, et al. Abstracts from the ASENT 2010 annual meeting March 4–6, 2010 Neurotherapeutics. 7: 328-333. DOI: 10.1016/J.Nurt.2010.06.003  0.456
2009 Nahab FB, Hattori N, Saad ZS, Hallett M. Contagious yawning and the frontal lobe: an fMRI study. Human Brain Mapping. 30: 1744-51. PMID 18937281 DOI: 10.1002/Hbm.20638  0.381
2009 Haubenberger D, Nahab F, Toro C, Wittevrongel L, Lungu C, Hallett M, McLane JA. Abstract #4: Therapeutic Effect of 1-Octanol in Essential Tremor Likely Mediated Through Octanoic Acid: Data from a High-Dose Extension Study Neurotherapeutics. 6: 605-605. DOI: 10.1016/J.Nurt.2009.03.005  0.619
2009 Turk P, Saxby BK, Bardwell M, Edgar C, Wesnes K, Gropman AL, Sailasuta N, Harris K, Ross B, Abulseoud O, Loane DJ, Matsuoka Y, Rebeck GW, Faden AI, Burns MP, ... ... Nahab F, et al. Abstracts from the ASENT 2009 Annual Meeting March 5–7, 2009 Neurotherapeutics. 6: 604-606. DOI: 10.1016/J.Nurt.2009.03.002  0.617
2008 Nahab FB, Peckham EL, Hallett M. Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome. Neurology. 71: 950-1. PMID 18794499 DOI: 10.1212/01.Wnl.0000325994.93782.A1  0.433
2008 NAHAB F, WITTEVRONGEL L, HALLETT M. Poster Abstract #4: Development of Long-Duration Accelerometry for Use in Clinical Trials of Essential Tremor Neurotherapeutics. 5: 491-491. DOI: 10.1016/J.Nurt.2008.03.005  0.487
2008 VanDenburgh A, Shah MV, Hua S, Abu-Shakra S, Wagg J, Khariton T, Beddingfield FC, Brin MF, Herr BE, Hart KA, McDermott M, Griggs RC, Herbelin L, Barohn R, Loane DJ, ... ... Nahab F, et al. Abstracts from the ASENT 2008 Annual Meeting March 6–8, 2008 Neurotherapeutics. 5: 490-495. DOI: 10.1016/J.Nurt.2008.03.002  0.43
2007 Nahab FB, Peckham E, Hallett M. Essential tremor, deceptively simple.... Practical Neurology. 7: 222-33. PMID 17636137 DOI: 10.1136/Jnnp.2007.124693  0.412
2006 Pirio Richardson S, Matsuhashi M, Voon V, Peckham E, Nahab F, Mari Z, Matteson S, Maguire S, Apud J, Hallett M. FC36.3 Timing of the sense of volition in patients with schizophrenia Clinical Neurophysiology. 117: 1. DOI: 10.1016/J.Clinph.2006.06.120  0.368
Low-probability matches (unlikely to be authored by this person)
2012 Wallace DM, Shafazand S, Carvalho DZ, Nahab FB, Sengun C, Russell A, Moore HP, Singer C. Sleep-related falling out of bed in Parkinson's disease. Journal of Clinical Neurology (Seoul, Korea). 8: 51-7. PMID 22523513 DOI: 10.3988/Jcn.2012.8.1.51  0.298
2017 Luca CC, Nadayil G, Dong C, Nahab FB, Field-Fote E, Singer C. Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial. Journal of the Neurological Sciences. 379: 7-11. PMID 28716283 DOI: 10.1016/J.Jns.2017.05.011  0.296
2001 Nahab FB, Worrell GA, Weinshenker BG. 25-year-old man with recurring headache and confusion. Mayo Clinic Proceedings. 76: 75-8. PMID 11155417 DOI: 10.4065/76.1.75  0.285
2013 Nuytemans K, Bademci G, Kohli MM, Beecham GW, Wang L, Young JI, Nahab F, Martin ER, Gilbert JR, Benatar M, Haines JL, Scott WK, Züchner S, Pericak-Vance MA, Vance JM. C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease. Annals of Human Genetics. 77: 351-63. PMID 23845100 DOI: 10.1111/Ahg.12033  0.274
2017 Fleischer CC, Wu J, Qiu D, Park SE, Nahab F, Dehkharghani S. The Brain Thermal Response as a Potential Neuroimaging Biomarker of Cerebrovascular Impairment. Ajnr. American Journal of Neuroradiology. PMID 28935624 DOI: 10.3174/Ajnr.A5380  0.274
2010 Katzen H, Myerson C, Papapetropoulos S, Nahab F, Gallo B, Levin B. Multi-modal hallucinations and cognitive function in Parkinson's disease Dementia and Geriatric Cognitive Disorders. 30: 51-56. PMID 20689283 DOI: 10.1159/000314875  0.272
2000 Iacono RP, Nahab FB, Nahab FH. Serotonergic decompensation in the akinetic expression of Parkinson's disease. The International Journal of Neuroscience. 101: 57-63. PMID 10765990 DOI: 10.3109/00207450008986492  0.265
2010 Nahab FB. Exploring yawning with neuroimaging. Frontiers of Neurology and Neuroscience. 28: 128-33. PMID 20357471 DOI: 10.1159/000307093  0.261
2014 Levin BE, Katzen HL, Maudsley A, Post J, Myerson C, Govind V, Nahab F, Scanlon B, Mittel A. Whole-brain proton MR spectroscopic imaging in Parkinson's disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 24: 39-44. PMID 23228009 DOI: 10.1111/J.1552-6569.2012.00733.X  0.256
2009 Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Chimowitz MI. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 72: 2014-9. PMID 19299309 DOI: 10.1212/01.Wnl.0B013E3181A1863C  0.252
2010 Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Züchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Annals of Human Genetics. 74: 97-109. PMID 20070850 DOI: 10.1111/J.1469-1809.2009.00560.X  0.241
2012 Vance J, Bademci G, Nuytemans K, Beecham G, Edwards Y, Singer C, Nahab F, Rhodes S, Ritz B, Zuchner S, Haines J, Scott W. Identification of Rare Variants in Parkinson Disease Using Next-Generation Sequencing (S22.007) Neurology. 78: S22.007-S22.007. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S22.007  0.23
2021 Watts J, Khojandi A, Vasudevan R, Nahab FB, Ramdhani RA. Improving Medication Regimen Recommendation for Parkinson's Disease Using Sensor Technology. Sensors (Basel, Switzerland). 21. PMID 34065245 DOI: 10.3390/s21103553  0.188
2015 Dashtipour K, Chen JJ, Frei K, Nahab F, Tagliati M. Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 5: 338. PMID 26566457 DOI: 10.7916/D8CJ8CVR  0.179
2016 Nalci A, Khodamoradi A, Balkan O, Nahab F, Garudadri H. A computer vision based candidate for functional balance test. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2015: 3504-8. PMID 26737048 DOI: 10.1109/EMBC.2015.7319148  0.178
2016 Nalci A, Khodamoradi A, Balkan O, Nahab F, Garudadri H. A computer vision based candidate for functional balance test. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2015: 3504-8. PMID 26737048 DOI: 10.1109/EMBC.2015.7319148  0.178
2023 Longardner K, Wright BA, Alakkas A, You H, Xu R, Liu L, Nahab FB. Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis. Plos One. 18: e0278262. PMID 36706079 DOI: 10.1371/journal.pone.0278262  0.167
2011 Stroescu I, Salinas CM, Nahab FB, Stringer AY. Long-term neurocognitive and neuroimaging outcomes in posterior reversible encephalopathy syndrome: two case reports and implications. The Clinical Neuropsychologist. 25: 1386-402. PMID 22050322 DOI: 10.1080/13854046.2011.628339  0.153
2013 Luca CC, Nahab FB. Neuroimaging in Essential Tremor Current Clinical Neurology. 44: 185-199. DOI: 10.1007/978-1-62703-471-5_12  0.147
2013 Nahab FB, Hattori N. Neuroimaging of movement disorders Current Clinical Neurology. 44. DOI: 10.1007/978-1-62703-471-5  0.132
2019 Nahab FB, Abu-Hussain H, Moreno L. Evaluation of Clinical Utility of the Personal KinetiGraph<sup>&reg;</sup> in the Management of Parkinson Disease Advances in Parkinson's Disease. 8: 42-61. DOI: 10.4236/apd.2019.83005  0.079
2013 Nagpal SV, Lerakis S, Flueckiger PB, Halista M, Willis P, Block PC, Douglas JS, Morris DC, Liff DA, Stewart J, Devireddy C, Veledar E, Nahab FB, Babaliaros VC. Long-term outcomes after percutaneous patent foramen ovale closure. The American Journal of the Medical Sciences. 346: 181-6. PMID 23328836 DOI: 10.1097/MAJ.0b013e318276b071  0.046
2009 Nahab FB, Chimowitz MI. Anticoagulation Intracranial Atherosclerosis. 173-180. DOI: 10.1002/9781444300673.ch14  0.035
2013 Nahab FB, Hattori N. Preface Current Clinical Neurology. 44.  0.01
2011 Nahab FB, Qureshi S. Antithrombotics for Ischemic Stroke Inpatient Anticoagulation. 205-222. DOI: 10.1002/9781118067178.ch10  0.01
Hide low-probability matches.